Adicet Net Income From Continuing Ops from 2010 to 2024

ACET Stock  USD 1.01  0.09  8.18%   
Adicet Bio Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. From the period from 2010 to 2024, Adicet Bio Net Loss quarterly data regression had mean square error of 695.2 T and mean deviation of  25,740,988. View All Fundamentals
 
Net Loss  
First Reported
2000-09-30
Previous Quarter
-29.9 M
Current Value
-30.5 M
Quarterly Volatility
28.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Adicet Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adicet Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 M, Interest Expense of 23.8 K or Selling General Administrative of 34.7 M, as well as many indicators such as Price To Sales Ratio of 12.57, Dividend Yield of 0.0 or PTB Ratio of 0.45. Adicet financial statements analysis is a perfect complement when working with Adicet Bio Valuation or Volatility modules.
  
Check out the analysis of Adicet Bio Correlation against competitors.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Latest Adicet Bio's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Adicet Bio over the last few years. It is Adicet Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adicet Bio's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Adicet Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(54,228,673)
Coefficient Of Variation(66.34)
Mean Deviation25,740,988
Median(36,678,000)
Standard Deviation35,975,860
Sample Variance1294.3T
Range106M
R-Value(0.71)
Mean Square Error695.2T
R-Squared0.50
Significance0
Slope(5,695,192)
Total Sum of Squares18119.7T

Adicet Net Income From Continuing Ops History

2024-135.5 M
2023-142.7 M
2022-69.8 M
2021-62 M

About Adicet Bio Financial Statements

Adicet Bio shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Adicet Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Adicet Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Adicet Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-142.7 M-135.5 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.